These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15901944)

  • 41. Photodynamic therapy and endoscopic mucosal resection for Barrett's dysplasia and early esophageal adenocarcinoma.
    Wolfsen HC; Hemminger LL; Raimondo M; Woodward TA
    South Med J; 2004 Sep; 97(9):827-30. PubMed ID: 15455964
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Photodynamic therapy (PDT) for oesophageal dysplasia and early carcinoma with mTHPC (m-tetrahydroxyphenyl chlorin): a preliminary study.
    Javaid B; Watt P; Krasner N
    Lasers Med Sci; 2002; 17(1):51-6. PubMed ID: 11845368
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Photodynamic therapy for treatment of early adenocarcinoma in Barrett's esophagus.
    Overholt B; Panjehpour M; Tefftellar E; Rose M
    Gastrointest Endosc; 1993; 39(1):73-6. PubMed ID: 8454152
    [No Abstract]   [Full Text] [Related]  

  • 44. The role of photodynamic therapy in the esophagus.
    Gross SA; Wolfsen HC
    Gastrointest Endosc Clin N Am; 2010 Jan; 20(1):35-53, vi. PubMed ID: 19951793
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results.
    Overholt BF; Panjehpour M; Halberg DL
    Gastrointest Endosc; 2003 Aug; 58(2):183-8. PubMed ID: 12872083
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patient predictors of histopathologic response after photodynamic therapy of Barrett's esophagus with high-grade dysplasia or intramucosal carcinoma.
    Yachimski P; Puricelli WP; Nishioka NS
    Gastrointest Endosc; 2009 Feb; 69(2):205-12. PubMed ID: 18950764
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multilayered epithelium may be found in patients with Barrett's epithelium and dysplasia or adenocarcinoma.
    Upton MP; Nishioka NS; Ransil BJ; Rosenberg SJ; Puricelli WP; Zwas FR; Shields HM
    Dig Dis Sci; 2006 Oct; 51(10):1783-90. PubMed ID: 16967312
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Buried dysplasia and early adenocarcinoma arising in barrett esophagus after porfimer-photodynamic therapy.
    Mino-Kenudson M; Ban S; Ohana M; Puricelli W; Deshpande V; Shimizu M; Nishioka NS; Lauwers GY
    Am J Surg Pathol; 2007 Mar; 31(3):403-9. PubMed ID: 17325482
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of endoscopic treatment modalities for Barrett's neoplasia.
    David WJ; Qumseya BJ; Qumsiyeh Y; Heckman MG; Diehl NN; Wallace MB; Raimondo M; Woodward TA; Wolfsen HC
    Gastrointest Endosc; 2015 Nov; 82(5):793-803.e3. PubMed ID: 26071064
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Photodynamic therapy for gastrointestinal disease.
    Petersen BT; Chuttani R; Croffie J; DiSario J; Liu J; Mishkin D; Shah R; Somogyi L; Tierney W; Wong Kee Song LM
    Gastrointest Endosc; 2006 Jun; 63(7):927-32. PubMed ID: 16733105
    [No Abstract]   [Full Text] [Related]  

  • 51. Endoscopic therapy of Barrett's: what more do we need to know?
    Van Laethem JL; Devière J
    Gut; 2004 Jun; 53(6):779-80. PubMed ID: 15138200
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endoscopic ablation of Barrett's oesophagus: a randomized-controlled trial of photodynamic therapy vs. argon plasma coagulation.
    Kelty CJ; Ackroyd R; Brown NJ; Stephenson TJ; Stoddard CJ; Reed MW
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1289-96. PubMed ID: 15606390
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Photofrin to treat precancerous lesions in Barrett's esophagus.
    FDA Consum; 2003; 37(6):4. PubMed ID: 14983805
    [No Abstract]   [Full Text] [Related]  

  • 54. Photodynamic therapy for Barrett's esophagus: a review.
    Kelty CJ; Marcus SL; Ackroyd R
    Dis Esophagus; 2002; 15(2):137-44. PubMed ID: 12220421
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endoprevention of esophageal cancer: endoscopic ablation of Barrett's metaplasia and dysplasia.
    Wolfsen HC
    Expert Rev Med Devices; 2005 Nov; 2(6):713-23. PubMed ID: 16293098
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of Barrett's esophagus with high-grade dysplasia.
    McAllaster JD; Buckles D; Al-Kasspooles M
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):303-16. PubMed ID: 19275509
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Photodynamic therapy for Barrett's esophagus: clinical update.
    Overholt BF; Panjehpour M
    Am J Gastroenterol; 1996 Sep; 91(9):1719-23. PubMed ID: 8792687
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A new long-range through-the-scope balloon applicator for photodynamic therapy in the esophagus and cardia.
    Gossner L; May A; Sroka R; Ell C
    Endoscopy; 1999 Jun; 31(5):370-6. PubMed ID: 10433046
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Barrett's esophagus.
    Falk GW
    Gastrointest Endosc Clin N Am; 1994 Oct; 4(4):773-89. PubMed ID: 7812646
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Photodynamic therapy using 5-aminolaevulinic acid for the treatment of dysplasia in Barrett's oesophagus.
    Dunn J; Lovat L
    Expert Opin Pharmacother; 2008 Apr; 9(5):851-8. PubMed ID: 18345960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.